Boai NKY Pharmaceuticals Ltd

Boai NKY Pharmaceuticals, listed on the Shenzhen stock exchange, was the first domestic Chinese company to develop and manufacture PVP and PVM/MA products and ranks as the third-largest global PVP manufacturer, with its KoVidone and PolyKoVidone lines representing povidone, crospovidone and copovidone pharmaceutical excipients. KoVidone-I (PVP-I) serves as a broad-spectrum biocidal, antifungal and antiviral agent, while its OraRez line of PVM/MA copolymer and derivatives serves bioadhesive/mucoadhesive applications, alongside pharmaceutical solvents and intermediates. NKY was the first Chinese manufacturer to receive EXCiPACT GMP certification, manufacturing all products under strict cGMP guidelines in Class D cleanrooms with fully validated QC equipment and audit-trail compliance.